The pharmaceutical industry has untold billions available to make its case for unfettered actions on every front – pricing, clinical trials, marketing, safety regulation, trade policy, and more. Some of the money is spent influencing state and federal lawmakers. Other funding goes to fake grassroots groups or to fund patient advocacy groups and various medical provider specialty associations. Still more money is invested in sophisticated marketing campaigns, data mining, and public relations. The pharmaceutical industry even commissioned a thriller with a plot involving the importation of counterfeit drugs as part of its public relations offensive. Drug manufacturers, PBMs and other cogs in this complex and powerful industry have been repeatedly sued, and have paid billions in fines and payments to resolve criminal and civil charges, in cases brought by states, the federal government and industry whistleblowers.

Researching this Issue

News articles, reports and background information on pharmaceutical industry lobbying and spending are posted here. Relevant materials are also posted on the issue pages on Medicaid & Medicare, which includes information on false claims act and other fraud cases; Advertising & Marketing, on industry activities to market drugs to medical providers and the general public; Pricing, which has information on drug prices; Safety & Clinical Trials which has information on how the industry influences medical practice guidelines and drug safety trials; Importation, which has information comparing drug prices in the U.S. with prices I other countries; Trade, which details the industry’s role influencing trade policy; and Pharmacy Benefit Managers, about the drug industry middlemen that negotiate between manufacturers and benefit plans. See also the Related Links below to connect to other organizations and materials relevant to this issue.


Related News
May 04, 2008
ZNet
Big Pharma Digs In | >>more
May 02, 2008
Pharmalot
Pfizer Lobbyist: Kickbacks To Docs Are Bad | >>more
May 02, 2008
Pharmalot
Merck’s Dick Clark Has An Epiphany | >>more
>> view all News
 
Reports
Mar 12, 2008
IMS Health Reports U.S. Prescription Sales Grew 3.8 Percent in 2007, to $286.5 Billion | >>more
Aug 03, 2006
Study of Industry Funding of Patient Organizations | >>more
Apr 21, 2006
Provisions Written By Special Interests Waste $80 Billion Annually on Drug Benefits | >>more
>> view all Reports
 
Research The Issues:
 
Search The Site:
 
NLARx Newsletter:
Learn more | View Archive
 
Join NLARx Today
arrow Membership Details
arrow Member News Page